NO994309L - Fremgangsmaater for undertrykkelse av tumorvekst med kombinasjoner av isoprenoider og statiner - Google Patents

Fremgangsmaater for undertrykkelse av tumorvekst med kombinasjoner av isoprenoider og statiner

Info

Publication number
NO994309L
NO994309L NO994309A NO994309A NO994309L NO 994309 L NO994309 L NO 994309L NO 994309 A NO994309 A NO 994309A NO 994309 A NO994309 A NO 994309A NO 994309 L NO994309 L NO 994309L
Authority
NO
Norway
Prior art keywords
statins
tumor growth
isoprenoids
combinations
methods
Prior art date
Application number
NO994309A
Other languages
English (en)
Other versions
NO994309D0 (no
Inventor
Charles Elson
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of NO994309L publication Critical patent/NO994309L/no
Publication of NO994309D0 publication Critical patent/NO994309D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

En fremgangsmåte for hemming av tumorvekst blir beskrevet. I en utførelsesform omfatter fremgangsmåten trinnet ved å eksponere tumorceller for en effektiv mengde av en sammensetning omfattende minst to forbindelser valgt blant gruppen omfattende tocotrienoler, statiner og iononer.
NO994309A 1997-03-04 1999-09-03 FremgangsmÕter for undertrykkelse av tumorvekst med kombinasjoner av isoprenoider og statiner NO994309D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3979097P 1997-03-04 1997-03-04
PCT/US1998/003470 WO1998038993A1 (en) 1997-03-04 1998-02-23 Method of suppressing tumor growth with combinations of isoprenoids and statins

Publications (2)

Publication Number Publication Date
NO994309L true NO994309L (no) 1999-09-03
NO994309D0 NO994309D0 (no) 1999-09-03

Family

ID=21907353

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994309A NO994309D0 (no) 1997-03-04 1999-09-03 FremgangsmÕter for undertrykkelse av tumorvekst med kombinasjoner av isoprenoider og statiner

Country Status (13)

Country Link
US (2) US6133312A (no)
EP (1) EP0986383A1 (no)
JP (1) JP2001507363A (no)
KR (1) KR20000075919A (no)
AU (1) AU729355B2 (no)
BR (1) BR9808157A (no)
CA (1) CA2283333A1 (no)
HU (1) HUP0002049A2 (no)
IL (1) IL131628A0 (no)
NO (1) NO994309D0 (no)
PL (1) PL335506A1 (no)
RU (1) RU2179440C2 (no)
WO (1) WO1998038993A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642268B2 (en) * 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US6239114B1 (en) * 1997-09-26 2001-05-29 Kgk Synergize Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols
US6251400B1 (en) * 1997-09-26 2001-06-26 Kgk Synergize Inc Compositions and methods of treatment of neoplastic diseases and hypercholesterolemia with citrus limonoids and flavonoids and tocotrienols
US6703384B2 (en) * 1998-09-23 2004-03-09 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
US20030017215A1 (en) * 1998-12-07 2003-01-23 Steven M. Bessette Cancer treatment composition and method using natural plant essential oils with signal transduction modulators
NZ520798A (en) * 2000-02-11 2004-05-28 Res Dev Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
US20030104090A1 (en) * 2000-05-05 2003-06-05 Levy Pedro E. Supplements containing annatto extracts and carotenoids and methods for using the same
US6566397B2 (en) * 2000-07-18 2003-05-20 Wisconsin Alumni Research Foundation Acyclic isoprenoid ether derivatives as chemotherapeutics
US20030236301A1 (en) * 2001-12-19 2003-12-25 Bob Sanders Liposomal delivery of vitamin E based compounds
US7074825B2 (en) * 2002-03-07 2006-07-11 Huanbiao Mo Composition and method for treating cancer
US20040202740A1 (en) * 2003-04-08 2004-10-14 Barrie Tan Annatto extract compositions, including geranyl geraniols and methods of use
US7989006B2 (en) * 2003-04-08 2011-08-02 American River Nutrition, Inc. Annatto extract compositions, including geranyl geraniols and methods of use
US20050037102A1 (en) * 2003-07-18 2005-02-17 Barrie Tan Annatto extract compositions including tocotrienols and tocopherols and methods of use
JPWO2005094814A1 (ja) * 2004-03-31 2008-02-14 興和株式会社 外用剤
EP1748774B1 (en) * 2004-05-26 2010-12-15 KGK Synergize, Inc. Compositions comprising flavonoids and tocotrienols and uses thereof
DE102006008074B4 (de) * 2006-02-22 2013-08-14 RUHR-UNIVERSITäT BOCHUM Behandlung von Krebs mit Geruchsrezeptor-Liganden
US8288369B2 (en) * 2006-06-27 2012-10-16 University Of South Florida Delta-tocotrienol treatment and prevention of pancreatic cancer
US20090004290A1 (en) * 2007-06-30 2009-01-01 Voelker Kirk G Red yeast rice compound for cancer chemoprevention
US8268786B2 (en) * 2009-04-23 2012-09-18 First Tech International Limited Anti-cancer tocotrienol analogues and associated methods
US9180113B2 (en) * 2009-09-01 2015-11-10 First Tech International Limited Tocotrienol compositions
EP2531028B1 (en) * 2010-02-05 2014-12-31 First Tech International Limited Tocotrienol esters
US9132117B2 (en) 2013-06-17 2015-09-15 Kgk Synergize, Inc Compositions and methods for glycemic control of subjects with impaired fasting glucose
WO2015039029A1 (en) 2013-09-13 2015-03-19 The Board Of Trustees Of The University Of Arkansas Preparation and use of a composition for prevention and mitigation of the effects of radiation
US20160324914A1 (en) 2015-05-05 2016-11-10 Tocol Pharmaceuticals, Llc Use of rice bran oil distillate extract for prevention and mitigation of the effects of radiation

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34617A (en) * 1862-03-04 Improved cylinder for grain scouring and thrashing machines
US33885A (en) * 1861-12-10 Improvement
USRE33885E (en) 1975-11-03 1992-04-14 The Procter & Gamble Company Compositions for inhibiting absorption of cholesterol
US4005196A (en) 1976-02-12 1977-01-25 The Procter & Gamble Company Vitaminized compositions for treating hypercholesterolemia
US4789554A (en) * 1985-12-05 1988-12-06 The Procter & Gamble Company High temperature vacuum steam distillation process to purify and increase the frylife of edible oils
JPH029875A (ja) * 1988-03-16 1990-01-12 Bio Ind Kyokai トコフェロール及びトコトリエノールの製造方法
DE3903991A1 (de) * 1989-02-10 1990-08-30 Basf Ag Phenylhydrazone des (beta)-jonons, ihre herstellung und daraus hergestellte arzneimittel und kosmetika
US5217992A (en) * 1989-10-04 1993-06-08 Bristol-Myers Squibb Company Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders
US5554647A (en) * 1989-10-12 1996-09-10 Perricone; Nicholas V. Method and compositions for treatment and/or prevention of skin damage and aging
US5574063A (en) * 1989-10-12 1996-11-12 Perricone; Nicholas V. Method and compositions for topical application of ascorbic acid fatty acid esters for treatment and/or prevention of skin damage
US5157132A (en) * 1990-05-18 1992-10-20 Carotech Associates Integrated process for recovery of carotenoids and tocotrienols from oil
US5393776A (en) * 1990-09-14 1995-02-28 Bristol-Myers Squibb Company Tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
US5204373A (en) * 1991-08-26 1993-04-20 Bristol-Myers Squibb Company Farnesylated tetrahydro-naphthalenols as hypolipidemic agents
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
EP0543417A1 (en) * 1991-11-22 1993-05-26 Lipogenics, Incorporated Tocotrienols and tocotrienol-like compounds and methods for their use
AU4275793A (en) * 1992-02-25 1993-09-13 Warner-Lambert Company Cytoprotective compositions containing pyruvate and antioxidants
IL104736A0 (en) * 1992-03-27 1993-06-10 Zeagen Inc Method for producing beta-carotene using a fungal mated culture
WO1993023034A1 (en) * 1992-05-13 1993-11-25 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Use of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme a reductase as a modality in cancer therapy
US5376361A (en) * 1993-01-13 1994-12-27 Perricone; Nicholas V. Method and compositions for topical application to the skin for prevention and/or treatment of radiation-induced skin damage
US5411969A (en) * 1993-04-16 1995-05-02 Bristol-Myers Squibb Company Antihyperlipidemic/antioxidant dihydroquinolines
US5391765A (en) * 1993-04-16 1995-02-21 Bristol-Myers Squibb Company Cholesterol lowering/antioxidant nitroxides
US5475029A (en) * 1993-07-08 1995-12-12 The Board Of Trustees Of The Leland Stanford Junior University Farnesyl compounds as cholesterol lowering agents
US5500154A (en) * 1994-10-20 1996-03-19 The Procter & Gamble Company Detergent compositions containing enduring perfume

Also Published As

Publication number Publication date
RU2179440C2 (ru) 2002-02-20
AU6335198A (en) 1998-09-22
EP0986383A1 (en) 2000-03-22
CA2283333A1 (en) 1998-09-11
BR9808157A (pt) 2000-03-28
US6133312A (en) 2000-10-17
HUP0002049A2 (hu) 2000-10-28
WO1998038993A1 (en) 1998-09-11
US6441029B1 (en) 2002-08-27
PL335506A1 (en) 2000-04-25
JP2001507363A (ja) 2001-06-05
IL131628A0 (en) 2001-01-28
KR20000075919A (ko) 2000-12-26
NO994309D0 (no) 1999-09-03
AU729355B2 (en) 2001-02-01

Similar Documents

Publication Publication Date Title
NO994309L (no) Fremgangsmaater for undertrykkelse av tumorvekst med kombinasjoner av isoprenoider og statiner
TR199801361T2 (xx) Yeni ikameli imidazol bile�imleri.
EA199800667A1 (ru) Новые фенантридины
TR199801360T2 (xx) Yeni ikameli imidazol bile�imleri.
MD1616G2 (ro) Compuşi triciclici şi metodă de inhibare a receptorului tirozin kinazei pentru factorul de creştere epidermic, compoziţie farmaceutică, metode de prevenire a implantării blastocitului şi tratament al mamiferelor
AU2056197A (en) M-amidino phenyl analogs as factor xa inhibitors
NO975716D0 (no) Imidazolforbindelser
AU7585598A (en) Raf kinase inhibitors
BR9811099A (pt) Inibidores de urocinase
AU1296099A (en) Methods and compositions for treating dermatoses
DK125796A (da) I form af små molekyler foreliggende inhibitorer for rotamaseaktivitet
AU8175498A (en) Quinazoline analogs and related compounds and methods for treating inflammatory conditions
AU8693098A (en) Compositions and methods for treating diabetes
HK1028350A1 (en) Leptin as an inhibitor of tumor cell proliferation.
ATE250077T1 (de) Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und verwendung
AU2251901A (en) Methods and compounds for inhibiting MRP1
AU7266591A (en) Method and composition for enhancing performance
ES2182622A1 (es) Compuestos a base de compuestos de polialquil-1-oxa-diazaespirodecanos.
AU3401199A (en) Method and composition for treating psoriasis
WO2004008286A3 (en) Arrangements and methods for treating a subject
GB2324091A (en) Metalloproteinase inhibitors
AU6645398A (en) Method for protecting bytecode
IT1293777B1 (it) Processo per la preparazione di tetraazamacrocicli
AU4672597A (en) Method for treating urinary reflux
NO912782D0 (no) Fremgangsmaate for behandling av skrap av legeringer av sjeldne jordmetaller/overgangsmetaller.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application